Cargando…
A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Poli...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667161/ https://www.ncbi.nlm.nih.gov/pubmed/31361789 http://dx.doi.org/10.1371/journal.pone.0220610 |
_version_ | 1783440008675328000 |
---|---|
author | Chen, Yufan Watson, Tina R. Criss, Steven D. Eckel, Andrew Palazzo, Lauren Sheehan, Deirdre F. Kong, Chung Yin |
author_facet | Chen, Yufan Watson, Tina R. Criss, Steven D. Eckel, Andrew Palazzo, Lauren Sheehan, Deirdre F. Kong, Chung Yin |
author_sort | Chen, Yufan |
collection | PubMed |
description | More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model–Asia (LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U.S. Centers for Medicare & Medicaid Services (CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore’s low smoking prevalence and South Korea’s aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries. |
format | Online Article Text |
id | pubmed-6667161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-66671612019-08-07 A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea Chen, Yufan Watson, Tina R. Criss, Steven D. Eckel, Andrew Palazzo, Lauren Sheehan, Deirdre F. Kong, Chung Yin PLoS One Research Article More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model–Asia (LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U.S. Centers for Medicare & Medicaid Services (CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore’s low smoking prevalence and South Korea’s aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries. Public Library of Science 2019-07-30 /pmc/articles/PMC6667161/ /pubmed/31361789 http://dx.doi.org/10.1371/journal.pone.0220610 Text en © 2019 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Chen, Yufan Watson, Tina R. Criss, Steven D. Eckel, Andrew Palazzo, Lauren Sheehan, Deirdre F. Kong, Chung Yin A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title | A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title_full | A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title_fullStr | A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title_full_unstemmed | A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title_short | A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea |
title_sort | simulation study of the effect of lung cancer screening in china, japan, singapore, and south korea |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667161/ https://www.ncbi.nlm.nih.gov/pubmed/31361789 http://dx.doi.org/10.1371/journal.pone.0220610 |
work_keys_str_mv | AT chenyufan asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT watsontinar asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT crissstevend asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT eckelandrew asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT palazzolauren asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT sheehandeirdref asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT kongchungyin asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT chenyufan simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT watsontinar simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT crissstevend simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT eckelandrew simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT palazzolauren simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT sheehandeirdref simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea AT kongchungyin simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea |